| scholarly article | Q13442814 |
| P2093 | author name string | K A Bauer | |
| R D Rosenberg | |||
| B L Kass | |||
| T L Goodman | |||
| P2860 | cites work | Deficiency of protein C in congenital thrombotic disease | Q24600822 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays | Q34207986 | ||
| Anticoagulant properties of bovine plasma protein C following activation by thrombin | Q34241254 | ||
| The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin | Q34260789 | ||
| Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration | Q34262883 | ||
| Preparation and properties of bovine factor VIII (antihemophilic factor). | Q34285283 | ||
| Measurement of fibrinopeptide A in human blood | Q34463206 | ||
| Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity | Q34524635 | ||
| In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment | Q34611870 | ||
| A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin | Q34621106 | ||
| Familial protein S deficiency is associated with recurrent thrombosis | Q34622189 | ||
| Interaction of coagulation factor Xa with human platelets | Q35053163 | ||
| Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. | Q35345503 | ||
| Human prothrombin metabolism in normal man and in hypocoagulable subjects | Q35571574 | ||
| The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity | Q35905116 | ||
| Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium | Q36992682 | ||
| Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma | Q37049171 | ||
| Radioimmunoassay of Human Fibrinopeptide A | Q37488033 | ||
| Prothrombin is activated on vascular endothelial cells by factor Xa and calcium | Q37512352 | ||
| Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity | Q37678210 | ||
| Inhibition of activated factor XII by antithrombin-heparin cofactor | Q39404087 | ||
| 53 Antithrombin-heparin cofactor | Q39419979 | ||
| Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). | Q39459862 | ||
| Comparison of the inhibition of thrombin by three plasma protease inhibitors | Q39500526 | ||
| THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY | Q39512876 | ||
| Analysis of Disappearance Time-Curves After Single Injection of Labelled Proteins | Q39925681 | ||
| Statistical characterization of the random errors in the radioimmunoassay dose--response variable | Q39978506 | ||
| Antithrombin III deficiency and thromboembolism | Q40321605 | ||
| Antifactor Xa activity measured with amidolytic methods | Q43724784 | ||
| Purification and binding properties of human platelet factor four | Q44792619 | ||
| Inactivation of hepatitis B virus by heat in antithrombin III stabilized with citrate | Q45791757 | ||
| The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor | Q47962380 | ||
| Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin | Q52859484 | ||
| Rabbit plasma inhibitor of the activated species of blood coagulation factor X. Purification and some properties. | Q53718244 | ||
| Experience with a Low-cost Chair-type Detector System for the Determination of Radioactive Body Burdens of M.I.T. Radiation Workers | Q54335892 | ||
| Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. | Q55062462 | ||
| Anticoagulant Action of Heparin | Q59048517 | ||
| Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity | Q66941583 | ||
| The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V | Q66971115 | ||
| Activated protein C inhibits platelet prothrombin-converting activity | Q66971257 | ||
| The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2 | Q67019140 | ||
| Inhibition of human factor IXa by human antithrombin | Q67340338 | ||
| Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function | Q67782418 | ||
| Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells | Q70056923 | ||
| Microvascular heparin-like species with anticoagulant activity | Q70298440 | ||
| Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex | Q70332055 | ||
| Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule | Q70366148 | ||
| Purification and properties of human platelet heparitinase | Q70453912 | ||
| Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation | Q70556596 | ||
| The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex | Q70648818 | ||
| Thrombin generation in acute promyelocytic leukemia | Q70957061 | ||
| Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia | Q71095977 | ||
| Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis | Q71172208 | ||
| Inactivation of human coagulation factor V by activated protein C | Q71243238 | ||
| Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families | Q71245149 | ||
| Coordinate binding of factor Va and factor Xa to the unstimulated platelet | Q71440229 | ||
| Studies with 131I-labelled antithrombin III in dogs | Q71539953 | ||
| Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme | Q71600014 | ||
| Functional prothrombinase complex assembly on isolated monocytes and lymphocytes | Q71766776 | ||
| Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C | Q71854044 | ||
| Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C | Q71857877 | ||
| Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma | Q72733340 | ||
| Thrombin and plasmin activity and platelet activation in the development of venous thrombosis | Q72776609 | ||
| Plasma protein S deficiency in familial thrombotic disease | Q72829571 | ||
| The purification of human prothrombin | Q72958790 | ||
| Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur | Q78915259 | ||
| Automated quantitation of proteins in serum and other biologic fluids | Q93733715 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | congenital disorder | Q727096 |
| P304 | page(s) | 826-836 | |
| P577 | publication date | 1985-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency | |
| P478 | volume | 76 |
| Q38817825 | A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjects. |
| Q40582622 | Activation markers of coagulation |
| Q35582687 | Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study |
| Q81513284 | Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass |
| Q39505366 | Clearance of thrombin in vivo: significance of alternative pathways |
| Q50942675 | Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy. |
| Q40510653 | Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency |
| Q46058924 | Does earthquake-induced cardiovascular disease persist or is it suppressed after the major quake? |
| Q39626396 | Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. |
| Q70065691 | Heparan sulphate with no affinity for antithrombin III and the control of haemostasis |
| Q35867026 | Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion |
| Q33801932 | Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know |
| Q43968706 | Locally activated coagulation induced by a peripheral endovenous catheter |
| Q73461281 | Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood |
| Q37252179 | Markers of thrombin and plasmin generation in patients with inherited thrombophilia |
| Q38020339 | Mechanisms of vitamin K antagonism |
| Q72221860 | Procoagulant activity and intimal dysfunction in IDDM |
| Q73127990 | Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies |
| Q68004018 | Pulmonary embolism in the elderly |
| Q73397573 | Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement |
| Q70466164 | Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells |
| Q35582723 | Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses |
| Q33717037 | Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood |
| Q39481040 | Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S. |
| Q71807649 | Tissue Factor Mediates Prolonged Procoagulant Activity on the Luminal Surface of Balloon-Injured Aortas in Rabbits |
| Q41293004 | Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations |
Search more.